Stephen Ubl ’91, a speech communication and political science graduate, has stepped down as president and CEO of AdvaMed, a medical technology trade group. He’s slated to be president and CEO of PhRMA, an association of biopharmaceutical research companies such as Bayer, AstraZeneca, GlaxoSmithKline and Bristol-Myers Squibb.
http://www.politico.com/tipsheets/politico-influence/2015/09/ubl-likely-to-be-next-phrma-ceo-210356